HRP ovarian cancer cells are often characterized by genetic alterations in signaling pathways that contribute to cell cycle dysregulation, such as cyclin E1 (encoded by CCNE1) and cyclin dependent kinase (CDK) genes (44). This evidence concerns the gene CCNE1 and ovarian carcinoma.